RT Journal Article
SR Electronic
T1 494 OR502, a best-in-class anti-LILRB2 antibody that enhances both innate and adaptive anti-tumor immune responses
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A556
OP A556
DO 10.1136/jitc-2023-SITC2023.0494
VO 11
IS Suppl 1
A1 Bouchlaka, Myriam N
A1 Zuck, Meghan
A1 Dinh, Huyen
A1 Green, Kevin
A1 Pisarenko, Tatyana
A1 Zapata, Francisco
A1 Hay, Elsa L
A1 Naika, Gajendra
A1 Heit, Jacob
A1 Fox, Ray
A1 Whitman, Darbie
A1 Graddis, Tom
A1 Puri, Kamal D
A1 Probst, Peter
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A556.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.